A solid dosage form of nilotinib is disclosed that comprises: (i) a core comprising 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide or a pharmaceutically acceptable salt thereof and excipients; and (ii) at least one polymer, said polymer coating said core, wherein disintegration of said solid dosage form is delayed.
申请公布号
WO2013074432(A1)
申请公布日期
2013.05.23
申请号
WO2012US64610
申请日期
2012.11.12
申请人
NOVARTIS AG;BHARDWAJ, UPKAR;BORDAWEKAR, MANGESH SADASHIV;COMFORT, ANN REESE;LI, PING;LI, SHOUFENG;MAKAROV, ALEXEY
发明人
BHARDWAJ, UPKAR;BORDAWEKAR, MANGESH SADASHIV;COMFORT, ANN REESE;LI, PING;LI, SHOUFENG;MAKAROV, ALEXEY